PDLIM7 and nasopharyngeal carcinoma: LMP1 and LMP2A were expressed in approximately 65% and 45.7% NPC patients, repectively [47], [48], and miR-155 was also found to be upregulated in many human tumors, which were not related to EBV [32], [33], [34], [37], [38], [42].